Review Of The Safety, Efficacy And Tolerability Of Fingolimod In The Treatment Of Pediatric Patients With Relapsing-Remitting Forms Of Multiple Sclerosis (RRMS)
Jenny Feng, Mary Rensel Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USACorrespondence: Mary RenselMellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, 9500 Euclid Ave. U10, Cleveland, OH 44195, USATel +1 216 444 8631Fax +1 2...
Main Authors: | Feng J, Rensel M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-11-01
|
Series: | Pediatric Health, Medicine and Therapeutics |
Subjects: | |
Online Access: | https://www.dovepress.com/review-of-the-safety-efficacy-and-tolerability-of-fingolimod-in-the-tr-peer-reviewed-article-PHMT |
Similar Items
-
Relapse Rate in Pediatric-Onset Multiple Sclerosis
by: J Gordon Millichap
Published: (2009-02-01) -
Long-Term Treatment Strategies of Pediatric Multiple Sclerosis, Including the use of Disease Modifying Therapies
by: Mary Rensel
Published: (2019-05-01) -
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis
by: Gajofatto A, et al.
Published: (2015-12-01) -
Multiple Sclerosis Relapsing Remitting Progressive Type
by: Nora Fitri, et al.
Published: (2020-12-01) -
The Outcome of COVID-19 in Pediatric-Onset Multiple Sclerosis Patients
by: Alici, N., et al.
Published: (2022)